Abstract
Calixarene nano-baskets enable to encapsulate the guest drugs and show different biological activities. This review deals with the behavior of calixarene-based drugs and illustrates their potentials in the pharmacological sciences. The role of calixarene’s scaffolds and substitutions in aspects of anti-cancer, anti-mycobacterial, anti-proliferativity, catalytic and inhibitory activities as well as solubility control, drug analysis, drug purification, drug supports and structural studies is reviewed.
Similar content being viewed by others
References
Vicens, J., Harrowfield, J., Baklouti, L.: Calixarenes in the nanoworld. Springer, Dordrecht (2007)
Mokhtari, B., Pourabdollah, K., Dalali, N.: Analytical applications of calixarenes from 2005 up-to-date. J. Incl. Phenom. Macrocycl. Chem. 69(1–2), 1–55 (2011)
Mokhtari, B., Pourabdollah, K., Dalali, N.: Molecule and ion recognition of nano-baskets of calixarenes since 2005. J. Coord. Chem. 64(5), 743–794 (2011)
Mokhtari, B., Pourabdollah, K.: Medical applications of nano-baskets. J. Coord. Chem. 64(18), 3189–3204 (2011)
Mutihac, L., Lee, J.H., Kim, J.S., Vicens, J.: Recognition of amino acids by functionalized calixarenes. Chem. Soc. Rev. 40(5), 2777–2796 (2011)
Mokhtari, B., Pourabdollah, K., Dallali, N.: A review of calixarene applications in nuclear industries, J. Radioanal. Nucl. Chem. 287(3), 921–934 (2011)
Mokhtari, B., Pourabdollah, K.: Competitive solvent extraction of alkaline earth metals by ionizable nano-baskets of calixarene. Supramol. Chem. (2011). doi:10.1080/10610278.2011.605452
Mokhtari, B., Pourabdollah, K.: Effect of crown size and upper moieties in nano-baskets of diacid calix[4]arene-1,2-crowns-3,4,5,6 on the extraction of s-block metals, J. Coord. Chem. 64(17), 3081–3091 (2011)
Zhang, D., Crawford, J.D., Bartsch, R.A.: Di-ionizable p-tert-Butylcalix[4]arene-1,2-monothiacrown-3 ligands in the cone conformation: synthesis and metal ion extraction. Tetrahedron 64(42), 9843–9849 (2008)
Zhang, D., Cao, X., Purkiss, D.W., Bartsch, R.A.: Di-ionizable p-tert-Butylcalix[4]arene-1,2-crown-3 ligands in cone and 1,2-alternate conformations: synthesis and metal ion extraction. Org. Biomol. Chem. 5, 1251–1259 (2007)
Tu, C., Surowiec, K., Bartsch, R.A.: Efficient divalent metal cation extractions with di-ionizable calix[4]arene-1,2-crown-4 compounds. Tetrahedron 63(19), 4184–4189 (2007)
Zhou, H., Surowiec, K., Purkiss, D.W., Bartsch, R.A.: Synthesis and alkaline earth metal cation extraction by proton di-ionizable p-tert-Butylcalix[4]arene-crown-5 compounds in cone, partial-cone and 1,3-alternate conformations. Org. Biomol. Chem. 4, 1104–1114 (2006)
Mokhtari, B., Pourabdollah, K., Dalali, N.: Applications of nano-baskets of calixarenes in chromatography. Chromatographia 73(9–10), 829–847 (2011)
Baeyer, A.: Ueber die verbindungen der aldehyde mit den phenolen. Chem. Ber. 5(1), 280–282 (1872)
Zinke, A., Ziegler, E.: Zur kenntnis des härtungsprozesses von phenol-formaldehyd-harzen. X. mitteilung. Chem. Ber. 77(3–4), 264–272 (1944)
Gutsche, C.D., Muthukrishnan, R.: Calixarenes 1. Analysis of the product mixtures by the bas-catalyzed condensation of formaldehyde with para-substituted phenols. J. Org. Chem. 43(25), 4905–4936 (1978)
Li, H., Zhang, Y., Wang, X., Xiong, D., Bai, Y.: Calixarene capped quantum dots as luminescent probes for Hg2+ ions. Mater. Lett. 61(7), 1474–1477 (2007)
Mokhtari, B., Pourabdollah, K.: Advances in binding ability and extractive applications of nano-baskets of calixarene. Asian J. Chem. 23(11), 4717–4734 (2011)
Ersoz, M.: Transport of mercury through liquid membranes containing calixarene carriers. Adv. Colloid Interface Sci. 134–135, 96–104 (2007)
Ding, C., Qu, K., Li, Y., Hu, K., Liu, H., Ye, B., Wu, Y., Zhang, S.: Preparation and characterization of six calixarene bonded stationary phases for high performance liquid chromatography. J. Chromatogr. A 1170(1–2), 73–81 (2007)
Cornforth, J.W., Hart, P.D., Nicholls, G.A., Rees, R.J., Stock, J.A.: Antituberculous effects of certain surface-active polyoxyethylene ethers. Br. J. Pharmacol. Chemother. 10(1), 73–88 (1955)
Rodik, R.V., Boyko, V.I., Kalchenko, V.I.: Calixarenes in bio-medical researches. Curr. Med. Chem. 16(13), 1630–1655 (2009)
Fatima, A., Fernandes, S.A., Sabino, A.A.: Calixarenes as new platforms for drug design. Curr. Drug Discov. Technol. 6(2), 151–170 (2009)
Salorinne, K., Nissinen, M.: Calixcrowns: synthesis and properties. J. Incl. Phenom. Macrocycl. Chem. 61(1–2), 11–27 (2008)
Kim, J.S., Vicens, J.: Progress of calixcrowns chemistry. J. Incl. Phenom. Macrocycl. Chem. 63(1–2), 189–193 (2009)
Sharma, K.R., Agrawal, Y.K.: Analytical potentialities of calix-crown ethers. Rev. Anal. Chem. 23(2), 133–158 (2004)
Shokova, E.A., Kovalev, V.V.: Thiacalixarenes—a new class of synthetic receptors. Russ. J. Org. Chem. 39(1), 1–28 (2003)
Lhoták, P.: Chemistry of thiacalixarenes. Eur. J. Org. Chem. 8, 1675–1692 (2004)
Ludwig, R.: Calixarenes for biochemical recognition and separation. Microchim. Acta 152(1–2), 1–19 (2005)
Jose, P., Menon, S.: Lower-rim substituted calixarenes and their applications. Bioinorg. Chem. Appl. 1, 1–17 (2007)
Agrawal, Y.K., Pancholi, J.P.: Analytical applications of thiacalixarenes: a review. Ind. J. Chem. 46A, 1373–1382 (2007)
Mokhtari, B., Pourabdollah, K.: Binding and extraction of alkali and alkaline earth metals by ionizable calix[4]arene-1,2-crown-3 conformers. J. Incl. Phenom. Macrocycl. Chem. (2011). doi:10.1007/s10847-011-0052-1
Lassaad, B., Najah, C., Mouna, M., Amel, B.O., Rym, A., Jong, S.K., Yang, K., Jacques, V.: Calixarenes enhanced as dendrimers. A mini review. Mini-Rev. Org. Chem. 3(3), 219–228 (2006)
Anthony, W., Loris, C., Baggetto, G., Nicoleta, A., Mickael, L., Michaud, H., Magnard, S.: Calixarene derivatives as anticancer agent. US Patent 20100056482, 7 Oct 2010
Singh, A.K., Venglarik, C.J., Bridges, R.J.: Development of chloride channel modulators. Kidney Int. 48, 985–993 (1995)
Atwood, J.L., Bridges, R.J., Juneja, R.K., Singh, A.K.: Calixarene chloride-channel blockers. US Patent 5489612, 7 Oct 2010
Li, H., Findlay, I.A., Sheppard, D.N.: The relationship between cell proliferation, Cl− secretion, and renal cyst growth: a study using CFTR inhibitors. Kidney Int. 66(5), 1926–1938 (2004)
Harris, S.J.: Calixarene-based compounds having antibacterial, antifungal, anticancer-HIV activity. WIPO Patent 019974, 27 July 1995
Krishnan, A.M., Lohrmann, R.: Calixarene conjugate diagnostic agents for computerized tomography and method for using same. US Patent 5846515, 8 Dec 1998
Neagu, M., Ion, R.M., Manda, G., Constantin, C., Radu, E., Cristu, Z.: Antitumoral effect of calixarenes in experimental photodynamic therapy with K562 tumor cell line, Rom. J. Biochem. 47(1), 17–35 (2010)
Bezouska, K., Snajdrova, R., Krenek, K., Vancurova, M., Kadek, A., Adamek, D., Lhotak, P., Kavan, D., Hofbauerova, K., Man, P., Bojarova, P., Kren, V.: Carboxylated calixarenes bind strongly to CD69 and protect CD69+ killer cells from suicidal cell death induced by tumor cell surface ligands. Bioorg. Med. Chem. 18(4), 1434–1440 (2010)
Colston, M.J., Hailes, H.C., Stavropoulos, E., Herve, A.C., Herve, G., Goodworth, K.J., Hill, A.M., Jenner, P., Hart, P.D., Tascon, R.E.: Antimycobacterial calixarenes enhance innate defense mechanisms in murine macrophages and induce control of mycobacterium tuberculosis infection in mice. Infect. Immun. 72(11), 6318–6323 (2004)
Hart, P.D.: Mycobacterium tuberculosis in macrophages: effect of certain surfactants and other membrane-active compounds. Science 162(3854), 686–689 (1968)
Rouge, P., Pires, V.S., Gaboriau, F., Dassonville-Klimpt, A., Guillon, J., Nascimento, S.D., Leger, J.M., Lescoat, G., Sonnet, P.: Antiproliferative effect on HepaRG cell cultures of new calix[4]arenes. J. Enzyme Inhib. Med. Chem. 25(2), 216–227 (2010)
Pires, V.S., Gaboriau, F., Guillon, J., Nascimento, S., Dassonville, A., Lescoat, G., Desplat, V., Rochette, J., Jarry, C., Sonnet, P.: Modulation of cell proliferation in rat liver cell cultures by new calix[4]arenes. J. Enzyme Inhib. Med. Chem. 21(3), 261–270 (2006)
Latxague, L., Gaboriau, F., Chassande, O., Leger, J.M., Pires, V., Rouge, P., Dassonville-Klimpt, A., Fardeau, S., Jarry, C., Lescoat, G., Guillon, J., Sonnet, P.: Antiproliferative effect on HepaRG cell cultures of new calix[4]arenes. Part II. J. Enzyme Inhib. Med. Chem. 26(2), 204–215 (2011)
Krenek, K., Kuldova, M., Hulíkova, K., Stibor, I., Lhotak, P., Dudic, M., Budka, J., Pelantova, H., Bezouska, K., Fiserova, A., Kren, V.: N-acetyl-d-glucosamine substituted calix[4]arenes as stimulators of NK cell-mediated antitumor immune response. Carbohydr. Res. 342(12–13), 1781–1792 (2007)
Kalchenko, V., Kukhar, V., Kosterin, S.: Calixarenes for drug design, Sci. Innov. 12(22), 816–823 (2007)
Hwang, K.M., Qi, Y.M., Liu, S.Y., Lee, T.C., Choy, W., Chen, J.: Antithrombotic treatment with calix(n)arene compounds. US Patent 5409959, 25 April 1995
Tsou, L.K., Dutschman, G.E., Gullen, E.A., Telpoukhovskaia, M., Cheng, Y.C., Hamilton, A.D.: Discovery of a synthetic dual inhibitor of HIV and HCV infection based on a tetrabutoxy-calix[4]arene scaffold. Bioorg. Med. Chem. Lett. 20(7), 2137–2139 (2010)
Dibama, H.M., Clarot, I., Fontanay, S., Salem, A.B., Mourer, M., Finance, C., Duval, R.E., Regnouf-de-Vains, J.B.: Towards calixarene-based prodrugs: Drug release and antibacterial behaviour of a water-soluble nalidixic acid/calix[4]arene ester adduct. Bioorg. Med. Chem. Lett. 19(10), 2679–2682 (2009)
Yang, W., Otto, D.P., Liebenberg, W., Villiers, M.M.: Effect of para-sulfonato-calix[n]arenes on the solubility, chemical stability, and bioavailability of a water insoluble drug nifedipine. Curr. Drug Discov. Technol. 5(2), 129–139 (2008)
Yang, W., Villiers, M.M.: Effect of 4-sulphonato-calix[n]arenes and cyclodextrins on the solubilization of niclosamide, a poorly water soluble anthelmintic. AAPS J. 7(1), 241–248 (2005)
Yang, W., Villiers, M.M.: Aqueous solubilization of furosemide by supramolecular complexation with 4-sulphonic calix[n]arenes. J. Pharm. Pharmacol. 56(6), 703–708 (2004)
Kunsagi-Mate, S., Vasapollo, G., Szabo, K., Bitter, I., Mele, G., Longo, L., Kollar, L.: Effect of covalent functionalization of C60 fullerene on its encapsulation by water soluble calixarenes. J. Incl. Phenom. Macrocycl. Chem. 60(2–3), 71–78 (2008)
Panchal, J.G., Patel, R.V., Menon, S.K.: Preparation and physicochemical characterization of carbamazepine (CBMZ): para-sulfonated calix[n]arene inclusion complexes. J. Incl. Phenom. Macrocycl. Chem. 67(1–2), 201–208 (2010)
Wang, G.S., Zhang, H.Y., Ding, F., Liu, Y.: Preparation and characterization of inclusion complexes of topotecan with sulfonatocalixarene. J. Incl. Phenom. Macrocycl. Chem. 69, 85–89 (2011)
Paclet, M.H., Rousseau, C.F., Yannick, C., Morel, F., Coleman, A.W.: An absence of non-specific immune response towards para-sulphonato-calix[n]arenes. J. Incl. Phenom. Macrocycl. Chem. 55(3–4), 353–357 (2006)
Mourer, M., Psychogios, N., Laumond, G., Aubertin, A.M., Regnouf-de-Vains, J.B.: Synthesis and anti-HIV evaluation of water-soluble calixarene-based bithiazolyl podands. Bioorg. Med. Chem. 18(1), 36–45 (2010)
Zareh, M.M., Malinowska, E.: Phosphorated calix[6]arene derivatives as an ionophore for atropine-selective membrane electrodes. J. AOAC Int. 90(1), 147–152 (2007)
Hashem, H., Jira, T.: The effect of the process variables on the HPLC separation of tricyclic neuroleptics on calixarene bonded stationary phase. Pharmazie 60(3), 186–192 (2005)
Hashem, H., Trundelberg, C., Jira, T.: Chromatographic application on calixarene bonded stationary phases: a stability indicating LC-method for determination of celecoxib in tablet formulation. Chromatographia 71(1–2), 91–94 (2010)
Al-Jammaz, I., Amartey, J.K., Namor, A.F., Vora, M.M., Lambrecht, R.M.: Novel separation of thallium-201 using p-tert-Butylcalix[4]arene derivative. Radiochim. Acta 88(3–4), 179–184 (2000)
Silva, D.L., Tavares, E.C., Conegero, L.S., Fatima, A., Pilli, R.A., Fernandes, S.A.: NMR studies of inclusion complexation of the pyrrolizidine alkaloid retronecine and p-sulfonic acid calix[6]arene. J. Incl. Phenom. Macrocycl. Chem. 69(1–2), 149–155 (2010)
Charnley, M., Fairfull-Smith, K., Williams, N.H., Haycock, J.W.: Evaluation of anti-inflammatory calixarene-peptides for biomaterial modification. Eur. Cells Mater. 11(3), 26 (2006)
Yordanov, A.T., Deal, K., Garmestani, K., Kobayashi, H., Herring, B., Waldmann, T.A., Brechbiel, M.W.: Synthesis and biodistribution study of a new 211At-calix[4]arene complex, J. Labelled Comp. Radiopharmaceuticals 43, 1219–1225 (2000)
Bommel, K.J.C., Verboom, W., Hulst, R., Kooijman, H., Spek, A.L., Reinhoudt, D.N.: calix[4]arene rhenium(V) complexes as potential radiopharmaceuticals. Inorg. Chem. 39(18), 4099–4106 (2000)
Inazumi, N., Yamamoto, S., Sueishi, Y.: A characteristic effect of pressure on inclusion complexation of phenothiazine dyes with p-sulfonato calix[6]arene in a room-temperature ionic liquid. J. Incl. Phenom. Macrocycl. Chem. 59(1–2), 33–39 (2007)
Sueishi, Y., Asano, K.: Effects of external pressure and solvent polarity on inclusion complexations of phenothiazine dyes and trans -4-[4-(dimethylamino)styryl]-1-methylpyridinium with water-soluble p-sulfonatocalix[8]arene in alcohol–water mixtures. J. Incl. Phenom. Macrocycl. Chem. 63(1–2), 37–42 (2009)
Inazumi, N., Sueishi, Y.: Inclusion complexation of octaethyl-p-tert-Butylcalix[8]arene octaacetate with methylene blue and control of its inclusion ability by alkali metal cations. J. Incl. Phenom. Macrocycl. Chem. 68(1–2), 93–98 (2010)
Fernandes, S.A., Cabeca, L.F., Marsaioli, A.J., Paula, E.: Investigation of tetracaine complexation with beta-cyclodextrins and p -sulphonic acid calix[6]arenes by NOE and PGSE NMR. J. Incl. Phenom. Macrocycl. Chem. 57(1–4), 395–401 (2007)
Acknowledgments
This work was supported by Islamic Azad University (Shahreza branch) and Iran Nanotechnology Initiative Council.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mokhtari, B., Pourabdollah, K. Applications of calixarene nano-baskets in pharmacology. J Incl Phenom Macrocycl Chem 73, 1–15 (2012). https://doi.org/10.1007/s10847-011-0062-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10847-011-0062-z